大眾篩檢市場：依產品類型、應用程式、性別、年齡層、交付方式、最終用戶和地區分類

2025 年大規模篩檢市場規模估計為 261 億美元，預計到 2032 年將達到 377.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 5.42%。

全球大規模篩檢市場已成為預防性醫療保健的重要組成部分，旨在及早發現和預防疾病。大規模篩檢涉及對無症狀人群進行系統性檢測，以識別可能患有特定疾病的人群，從而及時干預並改善健康狀況。隨著世界面臨日益加重的慢性病負擔和不斷上漲的醫療成本，有效的大規模篩檢計畫的重要性再怎麼強調也不為過。該市場涵蓋一系列篩檢和測試，例如基因篩檢、癌症篩檢、心血管篩檢和感染疾病篩檢。在人工智慧和基因組學融合等技術進步的推動下，大規模篩檢市場預計在未來幾年將經歷顯著的成長和創新。

市場動態：

全球大規模篩檢市場受多種因素驅動，包括慢性病盛行率上升、人們對疾病早期發現意識的增強以及政府推廣預防性醫療保健的措施。癌症、糖尿病和心血管疾病等疾病負擔日益加重，推動了對有效篩檢方案的需求，這些方案能夠識別高風險族群並及時介入。此外，液態切片、次世代定序醫療服務可近性有限，以及對假陽性結果和過度診斷的擔憂。此外，圍繞基因篩檢和資料隱私的監管挑戰和倫理考量也可能成為市場成長的障礙。儘管面臨這些挑戰，大規模篩檢市場仍為相關人員提供了重大機會。遠端醫療和遠端監控解決方案的日益普及可能會擴大篩檢方案的覆蓋範圍，尤其是在醫療服務不足的地區。此外，大規模篩檢與藥物基因組學和風險分層等個人化醫療方法相結合，可以實現有針對性的干涉並最佳化患者的治療效果。隨著全球醫療保健系統更加重視預防醫學和成本效益，大規模篩檢市場預計將在未來幾年見證顯著的成長和創新。

本研究的主要特點

• 本報告對全球大規模篩檢市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
• 它強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球大規模篩檢市場的主要企業概況。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球大規模篩檢市場報告涵蓋該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球大規模篩檢市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 限制因素
• 機會
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020 年至 2032 年全球大規模篩檢市場（依產品類型）

• 硬體設備
• 檢驗服務
• 結果分析與解釋

第5章。 2020 年至 2032 年按應用分類的全球大規模篩檢市場

• 腫瘤學
• 心臟病學
• 免疫學
• 神經病學
• 遺傳學和基因組學
• 內分泌與代謝
• 感染疾病
• 生殖及孕產婦健康
• 小兒科/新生兒科
• 精神病學和心理健康
• 血液學
• 胃腸病學
• 腎臟病學

6. 全球大規模篩檢市場（依性別分類），2020 年至 2032 年

• 男性
• 女士

7. 2020 年至 2032 年按年齡分類的全球大規模篩檢市場

• 兒科族群
• 成年人口
• 老年人口

8. 2020 年至 2032 年按交付類型分類的全球大規模篩檢市場

• 現場/設施篩檢
• 遠距/遠端醫療檢查
• 流動檢查組
• 自我檢測/在家檢測

9. 全球大規模篩檢市場（以最終用戶分類），2020 年至 2032 年

• 醫院
• 診斷實驗室
• 學術研究所
• 政府和公共衛生機構
• 專科診所
• 其他

第 10 章。 2020 年至 2032 年按地區分類的全球大規模篩檢市場

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第11章競爭格局

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN
• Hologic
• PerkinElmer
• Illumina
• Cepheid
• Genomic Health
• Agilent Technologies
• Ortho Clinical Diagnostics
• Becton, Dickinson and Company
• Beckman Coulter

第 12 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第13章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Population Screening Market is estimated to be valued at USD 26.10 Bn in 2025 and is expected to reach USD 37.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.42% from 2025 to 2032.

The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.

Market Dynamics:

The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.

Key Features of the Study:

• This report provides in-depth analysis of the global population screening market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Hardware Equipment
  • Diagnostic Devices
  • Sample Collection Devices
  • Imaging Equipment
  • Testing or Laboratory Services
  • Laboratory Testing Kits
  • Point-of-Care Testing
  • Blood and Urine Testing Services
  • Analytics or Interpretation
  • Software Solutions for Data Analysis
  • Interpretation Services
  • Reporting Tools
  • Others
• Application Area Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Cardiology
  • Immunology
  • Neurology
  • Genetics and Genomics
  • Endocrinology and Metabolism
  • Infectious Diseases
  • Reproductive and Maternal Health
  • Pediatrics and Neonatology
  • Psychiatry and Mental Health
  • Hematology
  • Gastroenterology
  • Nephrology
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Pediatric Population
  • Adult Population
  • Elderly Population
• Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
  • Onsite/Facility-Based Screening
  • Remote/Telehealth Screening
  • Mobile Screening Units
  • Self-Testing/Home-Based
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Government and Public Health Agencies
  • Specialty Clinics
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • QIAGEN
  • Hologic
  • PerkinElmer
  • Illumina
  • Cepheid
  • Genomic Health
  • Agilent Technologies
  • Ortho Clinical Diagnostics
  • Becton, Dickinson and Company
  • Beckman Coulter

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Population Screening Market, By Product Type
  • Global Population Screening Market, By Application Area
  • Global Population Screening Market, By Gender
  • Global Population Screening Market, By Age Group
  • Global Population Screening Market, By Delivery Mode
  • Global Population Screening Market, By End User
  • Global Population Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hardware Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Diagnostic Devices
    • Sample Collection Devices
    • Imaging Equipment
• Testing or Laboratory Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Laboratory Testing Kits
    • Point-of-Care Testing
    • Blood and Urine Testing Services
• Analytics or Interpretation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Software Solutions for Data Analysis
    • Interpretation Services
    • Reporting Tools
    • Others

5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetics and Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology and Metabolism
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reproductive and Maternal Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatrics and Neonatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Psychiatry and Mental Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nephrology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adult Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Elderly Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Onsite/Facility-Based Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Remote/Telehealth Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mobile Screening Units
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Self-Testing/Home-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Government and Public Health Agencies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genomic Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ortho Clinical Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us